Blood plasma pyruvate kinase as a marker of muscular dystrophy. Properties in dystrophic chickens and hamsters

This publication has 26 references indexed in Scilit:

• USE OF GENETICALLY DYSTROPHIC ANIMALS IN CHEMOTHERAPY TRIALS AND APPLICATION OF SEROTONIN ANTAGONISTS AS ANTIDYSTROPHIC DRUGS
  Annals of the New York Academy of Sciences, 1979
• Purification and Properties of the Pyruvate Kinase Isoenzymes Type L and M₂from Chicken Liver
  Hoppe-Seyler´s Zeitschrift Für Physiologische Chemie, 1977
• Postponement of symptoms of hereditary muscular dystrophy in chickens by 5-hydroxytryptamine antagonists
  Nature, 1976
• The effect of indomethacin on serum and skeletal muscle enzyme activities of dystrophic hamsters
  Biochemical Pharmacology, 1976
• Beneficial effects of penicillamine treatment on hereditary avian muscular dystrophy.
  Journal of Clinical Investigation, 1975
• Increased Activity of Pyruvate Kinase in Plasma of Vitamin E-deficient Rats
  Journal of Nutrition, 1975
• Properties of chicken skeletal muscle pyruvate kinase and a proposal for its evolutionary relation to the other avian and mammalian isoenzymes
  Biochemistry, 1975
• Serum pyruvate kinase in muscle disease and carrier states
  Neurology, 1974
• Pyruvate kinase isoenzymes in progressive muscular dystrophy and in acute myocardial infarction
  Metabolism, 1973
• COMPARISON OF PLASMA CREATINE PHOSPHOKINASE CHANGES IN NUTRITIONAL AND GENETIC MUSCULAR DYSTROPHY IN THE CHICKEN*
  Annals of the New York Academy of Sciences, 1966